Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
This contract is for the provision of a nurse led homecare service to administer intravenous COVID-19 neutralising monoclonal antibodies to eligible community patients registered with a GP in Surrey Heartlands or Frimley in line with NICE TA878.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Ashfield Healthcare Limited | 03286306 | ~£408,000 estimated from lot values | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately. 3 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 1,080 days (≈3 yrs) | £408,000 | 3 | Ashfield Healthcare Limited | active |
Weightings from the notice.
Government spending data: This supplier has received £20,967,775 in 36 payments (over £25k) from Department of Health and Social Care (2021-01-29 to 2022-04-26). View full payment history →
Changes the buyer published to this notice after it first appeared.
The anticipated activity volume for this contract is circa 120 patients per year.
The geographic coverage within the ICB will be East Surrey Place, Guildford & Waverley Place and Surrey Downs Place.
https://www.surreyheartlands.org/our-places https://www.eastsurrey-alliance.org/ https://www.guildfordwaverley-alliance.org/ https://www.surreydowns-hcp.org/
Following engagement with potential suitable providers for this service, considering the key criteria and applying the basic selection criteria in a fair way across all, the Awarding Authority has decided to halt the Most Suitable Provider process in favour of a Competitive Process which will be launched in the near future.
If at any point in the most suitable provider process the relevant authority has insufficient information to make an assessment under the most suitable provider process, for example, because it did not receive sufficient information to help its decision-making, it is advised to use the competitive process. If the relevant authority fails to identify the most suitable
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This contract has now been formally awarded using the competitive process.
The estimated lifetime value of the contract is £408,000. The contract will begin on 1st October 2024 for an initial period of 3 years until 30th September 2027.